Coherus Oncology, Inc. Common Stock
CHRS
CHRS
161 hedge funds and large institutions have $371M invested in Coherus Oncology, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 71 increasing their positions, 42 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
161
Holders Change
-2
Holders Change %
-1.23%
% of All Funds
2.54%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
27
Increased
71
Reduced
42
Closed
29
Calls
$665K
Puts
$954K
Net Calls
-$289K
Net Calls Change
-$958K
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$25.5M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$37.8M |
| 3 |
3
Morgan Stanley
New York
|
$12.9M |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$9.75M |
| 5 |
5
BlackRock
New York
|
$67.4M |
